‘Behind the Times’: Washington Tries to Catch Up With AI’s Use in Health Care
Lawmakers and regulators are trying to understand how AI is changing health care and how it should be regulated. The industry fears overreach.
Senators Weigh Whether Health Care AI Needs a Leash
The Senate Finance Committee contemplated the future yesterday: artificial intelligence and its potential applications to health care. And it turns out the future looks an awful lot like the past and present: Democrats want regulations. And the industry wants money. “There are a lot of reasons to be optimistic,” Finance Committee Chair Ron Wyden (D-Ore.) […]
When a Quick Telehealth Visit Yields Multiple Surprises Beyond a Big Bill
For the patient, it was a quick and inexpensive virtual appointment. Why it cost 10 times what she expected became a mystery.
GOP Presidential Hopefuls Use Trump’s Covid Record to Court Vaccine Skeptics
Candidates see former President Donald Trump’s embrace of his administration’s covid-19 vaccine policies as an opportunity to gain ground. So far, their efforts haven’t found traction.
Estrategia de Trump y sus adversarios de campaña: desinformar sobre las vacunas contra covid
La dinámica resultante podría impactar más allá del ciclo electoral, y afectar la política de salud pública en los próximos años. Y afectar a otras importantes vacunas.
Progressive and Anti-Abortion? New Group Plays Fast and Loose to Make Points
Progressive Anti-Abortion Uprising, which operates mostly in the nation’s capital, is part of a confrontational anti-abortion movement that embraces all types of media — graffiti, social media, and livestreams — to communicate a smashmouth message.
Nikki Haley (And Her Opponents) Struggle With a Vaccine Message
Former South Carolina governor Nikki Haley portrays herself as a voice of reason in the Republican Party. “Let’s find consensus,” she said about abortion during the first GOP primary debate. “Let’s treat this like a respectful issue.” It’s talk like that — and strong polling in a hypothetical matchup against President Biden — that has […]
Few Firm Beliefs and Low Trust: Americans Not Sure What’s True in Age of Health Misinformation
A new poll from KFF shows many Americans aren’t willing to embrace misinformation — but aren’t willing to reject it either. And they don’t know whom to trust.
The NIH Ices a Research Project. Is It Self-Censorship?
The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
FDA Head Robert Califf Battles Misinformation — Sometimes With Fuzzy Facts
FDA Commissioner Robert Califf has called misinformation one of the deadliest killers in the United States. As the FDA tries to fight that scourge, it sometimes stumbles.
How a Combination of Covid Lawsuits and Media Coverage Keeps Misinformation Churning
Even as the covid-19 pandemic wanes, litigation — whether about vaccines, masks, or a range of other public health policies made during the pandemic — isn’t about to end.
Need to Get Plan B or an HIV Test Online? Facebook May Know About It
Twelve of the largest drugstores in the U.S. sent shoppers’ sensitive health information to Facebook or other platforms, according to an investigation by The Markup and KFF Health News.
Tech Luminaries Give RFK Jr.’s Anti-Vaccine Message a Boost
The views of the leader of a broad anti-vaccine movement who is now running for president are unchallenged in public forums run by several prominent Silicon Valley figures.
How the Mixed Messaging of Vaccine Skeptics Sows Seeds of Doubt
Some GOP members of the House Select Subcommittee on the Coronavirus Pandemic have two-stepped around vaccine skepticism, proclaiming themselves to be pro-vaccine while also validating the beliefs of people who oppose vaccine mandates. The result could have serious public health consequences.
Las empresas quieren que sus IA tomen notas para los médicos y ofrezcan una segunda opinión, suponiendo que puedan evitar que divulgue la información privada de los pacientes.
AI May Be on Its Way to Your Doctor’s Office, But It’s Not Ready to See Patients
Giant corporations like Microsoft and Google, plus many startups, are eyeing health care profits from programs based on artificial intelligence.
Redes sociales alimentan obsesión por las drogas para bajar de peso, sin hablar de riesgos
La competencia para hacerse con un mercado que podría valer $100.000 millones al año, solo para los fabricantes de medicamentos, ha desencadenado una ola de publicidad que preocupa a las autoridades sanitarias y médicos de todo el mundo.
Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
Mark Cuban Has Been Taking On the Drug Industry. But Which One?
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
The Biggest, Buzziest Conference for Health Care Investors Convenes Amid Fears the Bubble Will Burst
This year’s JPMorgan confab, the first since covid’s chilling effect on such gatherings, was full of energy and enthusiasm. But it was also marked by questions about the future of health care investment.
